“Higher third quarter sales and continued backlog growth reflect the demand for our services and our progress in converting promising opportunities into new awards,” said
He continued, “Since joining
“This is an active and ongoing process that will take time to fully implement, but the direction is clear. We are aligning our resources behind the opportunities where
Third Quarter 2026 (“Q3 2026”) Results Overview
All comparisons are to the third quarter ended
Consolidated revenues for Q3 2026 rose 16% to
Consolidated gross margin for Q3 2026 declined to 45% of revenues from 49% of revenues. APC gross margin declined to 40% from 47% due to changes in project and product mix. FUEL CHEM gross margin was 49% compared to 50%.
SG&A expenses for Q3 2026 were
Interest income for Q3 2026 was
Net loss in Q3 2026 was
Adjusted EBITDA loss was
Consolidated APC segment backlog at
Financial Condition
As of
Conference Call
Management will host a conference call on
- (877) 423-9820 (Domestic) or
- (201) 493-6749 (International)
The conference call will also be accessible via the Upcoming Events section of the Company’s web site at www.ftek.com. Following management’s opening remarks, there will be a question-and-answer session.
About
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release contains “forward-looking statements” as defined in Section 21E of the Securities Exchange Act of 1934, as amended, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and reflect Fuel Tech’s current expectations regarding future growth, results of operations, cash flows, performance and business prospects, and opportunities, as well as assumptions made by, and information currently available to, our management.
CONTACT:
Managing Director
The
Devin.Sullivan@theequitygroup.com
Associate
Conor.Rodriguez@theequitygroup.com
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in thousands, except share and per-share data) | |||||||
| 2026 | 2025 | ||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 6,830 | $ | 11,939 | |||
| Short-term investments | 11,000 | 12,942 | |||||
| Accounts receivable, less current expected credit loss of | 5,891 | 5,355 | |||||
| Inventories, net | 382 | 373 | |||||
| Prepaid expenses and other current assets | 899 | 1,335 | |||||
| Total current assets | 25,002 | 31,944 | |||||
| Property and equipment, net of accumulated depreciation of | 4,688 | 4,739 | |||||
| 2,116 | 2,116 | ||||||
| Other intangible assets, net of accumulated amortization of | 587 | 646 | |||||
| Right-of-use operating lease assets, net | 480 | 536 | |||||
| Long-term investments | 9,950 | 6,991 | |||||
| Other assets | 208 | 207 | |||||
| Total assets | $ | 43,031 | $ | 47,179 | |||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable | 3,009 | $ | 3,242 | ||||
| Accrued liabilities: | |||||||
| Operating lease liabilities - current | 101 | 89 | |||||
| Employee compensation | 744 | 1,308 | |||||
| Other accrued liabilities | 1,124 | 1,634 | |||||
| Total current liabilities | 4,978 | 6,273 | |||||
| Operating lease liabilities - non-current | 421 | 491 | |||||
| Deferred income taxes, net | 187 | 187 | |||||
| Other liabilities | 294 | 296 | |||||
| Total liabilities | 5,880 | 7,247 | |||||
| Stockholders’ equity: | |||||||
| Common stock, | 324 | 322 | |||||
| Additional paid-in capital | 165,775 | 165,616 | |||||
| Accumulated deficit | (124,648 | ) | (121,796 | ) | |||
| Accumulated other comprehensive loss | (1,763 | ) | (1,718 | ) | |||
| Nil coupon perpetual loan notes | 76 | 76 | |||||
| (2,613 | ) | (2,568 | ) | ||||
| Total stockholders’ equity | 37,151 | 39,932 | |||||
| Total liabilities and stockholders’ equity | $ | 43,031 | $ | 47,179 | |||
| See notes to condensed consolidated financial statements. | |||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (in thousands, except share and per-share data) | |||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Revenues | $ | 8,676 | $ | 7,490 | $ | 21,241 | $ | 19,430 | |||||||
| Costs and expenses: | |||||||||||||||
| Cost of sales | 4,771 | 3,829 | 12,017 | 10,281 | |||||||||||
| Selling, general and administrative | 3,657 | 3,207 | 10,967 | 9,895 | |||||||||||
| Research and development | 771 | 450 | 1,941 | 1,510 | |||||||||||
| 9,199 | 7,486 | 24,925 | 21,686 | ||||||||||||
| Operating (loss) income | (523 | ) | 4 | (3,684 | ) | (2,256 | ) | ||||||||
| Interest income | 247 | 311 | 753 | 1,127 | |||||||||||
| Other income (expense), net | 9 | (5 | ) | 88 | 15 | ||||||||||
| (Loss) income before income taxes | (267 | ) | 310 | (2,843 | ) | (1,114 | ) | ||||||||
| Income tax expense | — | (7 | ) | (9 | ) | (11 | ) | ||||||||
| Net (loss) income | $ | (267 | ) | $ | 303 | $ | (2,852 | ) | $ | (1,125 | ) | ||||
| Net (loss) income per common share: | |||||||||||||||
| Basic net (loss) income per common share | $ | (0.01 | ) | $ | 0.01 | $ | (0.09 | ) | $ | (0.04 | ) | ||||
| Diluted net (loss) income per common share | $ | (0.01 | ) | $ | 0.01 | $ | (0.09 | ) | $ | (0.04 | ) | ||||
| Weighted-average number of common shares outstanding: | |||||||||||||||
| Basic | 31,217,000 | 31,074,000 | 31,164,000 | 30,890,000 | |||||||||||
| Diluted | 31,217,000 | 31,293,000 | 31,164,000 | 30,890,000 | |||||||||||
| See notes to condensed consolidated financial statements. | |||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (in thousands) | |||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Net (loss) income | $ | (267 | ) | $ | 303 | $ | (2,852 | ) | $ | (1,125 | ) | ||||
| Other comprehensive income (loss): | |||||||||||||||
| Foreign currency translation adjustments | (12 | ) | (14 | ) | (45 | ) | 132 | ||||||||
| Comprehensive (loss) income | $ | (279 | ) | $ | 289 | $ | (2,897 | ) | $ | (993 | ) | ||||
| See notes to condensed consolidated financial statements. | |||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in thousands) | |||||||
| Nine Months Ended | |||||||
| 2026 | 2025 | ||||||
| Operating Activities | |||||||
| Net loss | $ | (2,852 | ) | $ | (1,125 | ) | |
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||||
| Depreciation | 537 | 490 | |||||
| Amortization | 62 | 27 | |||||
| Loss on disposal of equipment | 15 | — | |||||
| Interest income on held-to-maturity securities, net of premium amortization and discount accretion | 81 | (91 | ) | ||||
| Provision for credit losses, net of recoveries | (1 | ) | — | ||||
| Stock-based compensation, net of forfeitures | 161 | 269 | |||||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable | (556 | ) | 3,066 | ||||
| Employee retention credit receivable | — | 1,677 | |||||
| Inventory | (9 | ) | (4 | ) | |||
| Prepaid expenses, other current assets and other non-current assets | 429 | 318 | |||||
| Accounts payable | (226 | ) | (560 | ) | |||
| Accrued liabilities and other non-current liabilities | (1,051 | ) | 516 | ||||
| Net cash (used in) provided by operating activities | (3,410 | ) | 4,583 | ||||
| Investing Activities | |||||||
| Purchases of equipment and patents | (505 | ) | (231 | ) | |||
| Purchases of debt securities | (12,102 | ) | (10,004 | ) | |||
| Maturities of debt securities | 11,000 | 11,000 | |||||
| Net cash (used in) provided by investing activities | (1,607 | ) | 765 | ||||
| Financing Activities | |||||||
| Taxes paid on behalf of equity award participants | (45 | ) | (222 | ) | |||
| Net cash used in financing activities | (45 | ) | (222 | ) | |||
| Effect of exchange rate fluctuations on cash | (47 | ) | 41 | ||||
| Net (decrease) increase in cash and cash equivalents | (5,109 | ) | 5,167 | ||||
| Cash and cash equivalents at beginning of period | 11,939 | 8,510 | |||||
| Cash and cash equivalents at end of period | $ | 6,830 | $ | 13,677 | |||
| See notes to condensed consolidated financial statements. | |||||||
Segment Data- Reporting Segments (Unaudited) (in thousands) | |||||||||||||||
| Information about reporting segment net sales and gross margin from operations is provided below: | |||||||||||||||
| Three months ended | Air Pollution Control Segment | FUEL CHEM Segment | Other | Total | |||||||||||
| Revenues from external customers | $ | 3,746 | $ | 4,930 | $ | — | $ | 8,676 | |||||||
| Cost of sales | (2,246 | ) | (2,525 | ) | — | (4,771 | ) | ||||||||
| Gross margin | 1,500 | 2,405 | — | 3,905 | |||||||||||
| Selling, general and administrative | — | — | (3,657 | ) | (3,657 | ) | |||||||||
| Research and development | — | — | (771 | ) | (771 | ) | |||||||||
| Income (loss) from operations | $ | 1,500 | $ | 2,405 | $ | (4,428 | ) | $ | (523 | ) | |||||
| Three months ended | Air Pollution Control Segment | FUEL CHEM Segment | Other | Total | |||||||||||
| Revenues from external customers | $ | 2,707 | $ | 4,783 | $ | — | $ | 7,490 | |||||||
| Cost of sales | (1,428 | ) | (2,401 | ) | — | (3,829 | ) | ||||||||
| Gross margin | 1,279 | 2,382 | — | 3,661 | |||||||||||
| Selling, general and administrative | — | — | (3,207 | ) | (3,207 | ) | |||||||||
| Research and development | — | — | (450 | ) | (450 | ) | |||||||||
| Income (loss) from operations | $ | 1,279 | $ | 2,382 | $ | (3,657 | ) | $ | 4 | ||||||
| Nine months ended | Air Pollution Control Segment | FUEL CHEM Segment | Other | Total | |||||||||||
| Revenues from external customers | $ | 8,135 | $ | 13,106 | $ | — | $ | 21,241 | |||||||
| Cost of sales | (5,010 | ) | (7,007 | ) | — | (12,017 | ) | ||||||||
| Gross margin | 3,125 | 6,099 | — | 9,224 | |||||||||||
| Selling, general and administrative | — | — | (10,967 | ) | (10,967 | ) | |||||||||
| Research and development | — | — | (1,941 | ) | (1,941 | ) | |||||||||
| Income (loss) from operations | $ | 3,125 | $ | 6,099 | $ | (12,908 | ) | $ | (3,684 | ) | |||||
| Nine months ended | Air Pollution Control Segment | FUEL CHEM Segment | Other | Total | |||||||||||
| Revenues from external customers | $ | 6,515 | $ | 12,915 | $ | — | $ | 19,430 | |||||||
| Cost of sales | (3,713 | ) | (6,568 | ) | — | (10,281 | ) | ||||||||
| Gross margin | 2,802 | 6,347 | — | 9,149 | |||||||||||
| Selling, general and administrative | — | — | (9,895 | ) | (9,895 | ) | |||||||||
| Research and development | — | — | (1,510 | ) | (1,510 | ) | |||||||||
| Income (loss) from operations | $ | 2,802 | $ | 6,347 | $ | (11,405 | ) | $ | (2,256 | ) | |||||
Geographic Segment Financial Data (Unaudited) (in thousands) | |||||||||||||||
| Information concerning our operations by geographic area is provided below. Revenues are attributed to countries based on the location of the end-user. Assets are those directly associated with operations of the geographic area. | |||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Revenues: | |||||||||||||||
| $ | 7,490 | $ | 5,626 | $ | 18,638 | $ | 15,427 | ||||||||
| Foreign | 1,186 | 1,864 | 2,603 | 4,003 | |||||||||||
| $ | 8,676 | $ | 7,490 | $ | 21,241 | $ | 19,430 | ||||||||
| 2026 | 2025 | ||||||
| Assets: | |||||||
| $ | 40,654 | $ | 44,345 | ||||
| Foreign | 2,377 | 2,834 | |||||
| $ | 43,031 | $ | 47,179 | ||||
RECONCILIATION OF GAAP NET LOSS TO EBITDA AND ADJUSTED EBITDA (Unaudited) (in thousands) | |||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Net Loss | $ | (267 | ) | $ | 303 | $ | (2,852 | ) | $ | (1,125 | ) | ||||
| Interest income | (247 | ) | (311 | ) | (753 | ) | (1,127 | ) | |||||||
| Income tax expense | - | 7 | 9 | 11 | |||||||||||
| Depreciation expense | 184 | 163 | 537 | 490 | |||||||||||
| Amortization expense | 18 | 9 | 62 | 27 | |||||||||||
| EBITDA | (312 | ) | 171 | (2,997 | ) | (1,724 | ) | ||||||||
| Stock compensation expense | 63 | 57 | 161 | 269 | |||||||||||
| Adjusted EBITDA | $ | (249 | ) | $ | 228 | $ | (2,836 | ) | $ | (1,455 | ) | ||||
Adjusted EBITDA
To supplement the Company's consolidated financial statements presented in accordance with generally accepted accounting principles in
Adjusted EBITDA is provided to enhance investors' overall understanding of the Company's current financial performance and ability to generate cash flow, which we believe is a meaningful measure for our investor and analyst communities. In many cases non-GAAP financial measures are utilized by these individuals to evaluate Company performance and ultimately determine a reasonable valuation for our common stock. A reconciliation of Adjusted EBITDA to the nearest GAAP measure of net income (loss) has been included in the above financial table.
Source: 